Makers Laboratories

Makers Laboratories EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Makers Laboratories (506919.BO) as of Oct 16, 2026 is 117.14 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 78.01 M INR — a change of 50.17% (higher).

EBITDA

117.14 MINR

YoY

50.17%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Makers Laboratories is 2026 117.14 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Makers Laboratories was 2025 78.01 M INR. It decreases by 50.17% higher compared to the previous year.

The Makers Laboratories EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
43.76 M INR
Jan 1, 2020
31.21 M INR
Jan 1, 2021
82.90 M INR
Jan 1, 2022
206.99 M INR
Jan 1, 2023
55.24 M INR
Jan 1, 2024
25.81 M INR
Jan 1, 2025
78.01 M INR
Jan 1, 2026
117.14 M INR
The Makers Laboratories EBITDA history
YEAREBITDAYoY
117.14 MINR+50.17%
78.01 MINR+202.21%
25.81 MINR-53.27%
55.24 MINR-73.31%
206.99 MINR+149.69%
82.90 MINR+165.63%
31.21 MINR-28.69%
43.76 MINR-2.57%
44.92 MINR-16.61%
53.86 MINR+15.43%
46.66 MINR+6.90%
43.65 MINR+74.72%
24.98 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India, operating within the Health Care sector. The company has a workforce of 121 employees and went public on July 13, 1993. It manufactures and markets pharmaceutical products, focusing on various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). Additionally, Makers Laboratories offers Inspira retail packs, covering categories like acid regulatory, anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics, anti-nauseants, anti-fungal, anti-hypertensives, and other health-related products. The Experia bulk packs division provides bulk pharmaceutical products including amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and similar items. The company's website is https://www.makerslabs.com/. Makers Laboratories Ltd is listed on the Bombay Stock Exchange under the ticker 506919.BO and holds the ISIN INE987A01010. The company operates through the pharmaceuticals segment, emphasizing general health therapeutic areas. It does not disclose specific financial figures or additional details beyond its product lines and operational structure. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Makers Laboratories is 117.14 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Makers Laboratories changed from 78.01 M INR to 117.14 M INR, representing a 50.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Makers Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Makers Laboratories

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Makers Laboratories